The collaborative efforts between Dr. Boye and Genzyme to develop a gene therapy for GUCY2D LCA1 were recently featured in a press release. A link to the aritcle can be found here: http://news.genzyme.com/press-release/genzyme-collaborates-gene-therapy-rare-disease-causes-childhood-blindness